U.S. Markets open in 55 hrs, 16 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 14.7702 09:40 AM EDT | |
|---|---|---|
| Day High | 15.32 09:30 AM EDT |
|
| Range | 0.55 |
| Volume | 1.00 M | |
|---|---|---|
| 30-Day Avg Vol | 1.37 M |
|
| Difference | -26.68% |
| Market Cap | 1.48 B | |
|---|---|---|
| Mkt Cap Chg | -57.99 M |
| Shares Out | 99.98 M | |
|---|---|---|
| % Shrs Traded | 1.01% | |
| 1yr EPS Est | 0.055 |
| 52-Wk Low | 9.93 3/6/09 | |
|---|---|---|
| 52-Wk High | 33.49 7/31/08 |
|
| Range | 23.56 |
| Prev Close | 15.46 7/1/09 | |
|---|---|---|
| Today's Open | 15.32 | |
| Change | -0.91% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 12.87 M |
| Revenue (LFY) | 296.49 M | |
|---|---|---|
| Earnings (LFY) | 30.83 M | |
| Earnings (MRQ) | -13.15 M | |
| Next Earn Est | -0.009 | |
| Next Earnings | 10/19/2009 |
|
| EPS (TTM) | 0.13 | |
| 1yr EPS Growth | -57.69% |
| P/E Ratio (TTM) | 35.43 | |
|---|---|---|
| P/E Ratio (Fwd) | 270.00 | |
| PEG Ratio | 8.33 | |
| Return on Equity | 12.74 | |
| Beta | 1.51 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
If spawning orphans makes for success in the drug world, then BioMarin Pharmaceutical takes the prize. The company has developed three FDA-approved drugs that qualify for orphan drug status, a financial ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.0090 7/30/09 | — — |
—
—
|
| Last Quarter | -0.118 3/31/09 | -0.13 3/31/09 |
-0.012
Missed
|
| 2 Quarters Ago | 0.258 12/31/08 | 0.21 12/31/08 |
-0.048
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 73.98 M | 296.49 M |
| Gross Profit | 58.52 M | 239.61 M |
| Operating Income | -4.60 M | 39.76 M |
| Net Income | -13.15 M | 30.83 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts